Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2000-5-25
pubmed:abstractText
1. Tyrosine kinases have been proposed as regulators of voltage-operated calcium channels. The effects of a range of structurally different inhibitors of protein tyrosine kinases (PTK) were examined on voltage-operated calcium channel currents (I(Ba)) and pp60(c-src) kinase (c-src) activity in vitro. 2. I(Ba) was measured in single myocytes isolated from rabbit ear artery by conventional whole cell voltage-clamp techniques. The activity of purified human c-src was measured in vitro using a non-radioactive assay. 3. Bath application of tyrphostin-23 and genistein (non-selective PTK inhibitors), bistyrphostin (a receptor-PTK-selective inhibitor) and PP1 (a src family-selective inhibitor) inhibited I(Ba) in a concentration-dependent manner over a range of test membrane potentials. Intracellular application of peptide-A, a peptide inhibitor of c-src also inhibited currents. Inhibitor potency series against I(Ba) was PP1 > genistein > tyrphostin 23 > bistyrphostin. 4. Tyrphostin-23, genistein, PP1, and peptide-A shifted the steady-state inactivation curves in a hyperpolarized direction without altering their slope. The inhibitors had no significant effects on I(Ba) activation calculated from current-voltage relationships. 5. The agents inhibited c-src activity in a concentration-dependent manner. The order of potency was PP1 > genistein > peptide-A > tyrphostin-23 > bistyrphostin. The IC(50) for inhibition of c-src activity was similar to the IC(50) for inhibition of I(Ba) in all cases. 6. Western blot analysis with a specific antibody to c-src showed the presence of this cytoplasmic tyrosine kinase in rabbit ear artery cells. 7. A range of structurally dissimilar inhibitors of PTKs inhibit I(Ba) and c-src activity with similar potency. These data provide further evidence implicating endogenous c-src in the modulation of L-type calcium channels in vascular smooth muscle cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-1326293, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-1336377, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-1862529, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-2052747, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-2065781, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-2171508, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-2475611, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-2850808, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-7495884, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-7712009, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-7997267, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8384532, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8388295, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8554555, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8557675, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8562808, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8575003, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8621613, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8732508, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8968578, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-8980120, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9019541, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9215709, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9310443, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9365813, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9365814, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9442882, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9641547, http://linkedlifedata.com/resource/pubmed/commentcorrection/10742290-9887969
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
129
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1347-54
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.
pubmed:affiliation
Imperial College School of Medicine, National Heart & Lung Institute, St Mary's Hospital, London W2 1NY, UK. v.wijetunge@ic.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't